Zurich Cantonal Bank
BIO icon

Zurich Cantonal Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Zurich Cantonal Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,381
Closed -$1.63M – 2689
2025
Q4 		$1.63M Buy
+5,381
New +$1.68M ﹤0.01% 1065

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Zurich Cantonal Bank's BIO Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2026: 6,370 shares worth $1.78M. The stake represents ﹤0.01% of the portfolio and ranks #1102 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in BIO as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in BIO in Q1 2015 and has held it in 44 quarters since. The position peaked at $6.15M in Q1 2023. 392 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Zurich Cantonal Bank held 6,370 shares of Bio-Rad Laboratories Class A worth $1.78M as of Q1 2026.
  • Bio-Rad Laboratories Class A was a new Zurich Cantonal Bank position in Q1 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1102 holding.
  • Zurich Cantonal Bank first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and has held it in 44 quarters since.
  • Zurich Cantonal Bank's Bio-Rad Laboratories Class A position peaked at $6.15M in Q1 2023.
  • 392 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.